Objectives: To investigate correlates of retention on the South Australian
Methadone Program during 1981-91.
Design: Retrospective study of a nonstratified random sample of 229 HIV-neg
ative clients who received methadone between January 1981 and June 1991. Da
ta were collected from clinical records of the 229 HIV-negative clients and
also from the 40 clients known to be infected with HIV during the decade.
Results: Being HIV positive, receiving larger maximum doses of methadone, r
eceiving methadone from a private pharmacy and enrolling later in the decad
e were all associated with longer retention times on the program.
Conclusions: This study supports the findings of previous studies, that max
imum dose of methadone is crucial to retention in methadone programs, But e
ven allowing for maximum dose, obtaining methadone from a private pharmacy
was also strongly associated with retention on the program. The more 'human
e' clinic policy later in the decade is likely to have increased retention
and reduced illicit drug use also.